Early and intermediate stages of wet AMD can be treated using medications, such as vascular endothelial growth factor (VEGF) inhibitors; and current clinical trials are also evaluating therapeutics that may slow the progression of GA [8, 9]. The gene discussed is VEGFA; the disease is wet macular degeneration.